ArticleBMC microbiology2018
Genetic polymorphisms identify in species/biovars of Brucella isolated in China between 1953 and 2013 by MLST.
Article in BMC microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- ONE Health Approach to Address Zoonotic Brucellosis: A Spatiotemporal Associations Study Between Animals and Humans.Frontiers in veterinary science · 2020Pooled it
- Identification and phylogenetic analysis of sevenFrontiers in cellular and infection microbiology · 2026Article
- Molecular Epidemiology ofVeterinary sciences · 2025Article
- Molecular epidemiological characteristics ofFrontiers in microbiology · 2023Article
- Changes in the epidemiological characteristics of human brucellosis in Shaanxi Province from 2008 to 2020.Scientific reports · 2021Article
- Whole-genome sequencing of roughEmerging microbes & infections · 2020Article
- Brucellosis in China: history, progress and challenge.Infectious diseases of poverty · 2020Article
- Molecular Characteristics ofFrontiers in microbiology · 2020Article
- A Novel Arthropod Host of Brucellosis in the Arid Steppe Ecosystem.Frontiers in veterinary science · 2020Article
- Investigation of the molecular characteristics of Brucella isolates from Guangxi Province, China.BMC microbiology · 2019Article
- Whole Genome Sequencing for Tracing Geographical Origin of Imported Cases of Human Brucellosis in Sweden.Microorganisms · 2019Article
- Genetic Characterization of AnimalBioMed research international · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundBrucellosis incidence in China is divided into three stages: high incidence (1950s-1960s), decline (1970s-1980s), and re-emergence (1990s-2010s). At the re-emergence stage, Brucellosis incidence grew exponentially and spread to all 32 provinces. We describe the magnitude and the etiological distribution changes in mainland China by genotyping data and emphasize its recent reemergence. We also provide the genetic diversity and molecular epidemiological characteristics of Brucella.
resultsFrom a total of 206 Brucella isolates, 19 MLST genotypes (STs) were identified and 13 new STs(ST71-83)were found. MLST grouped the population into three clusters. B. melitensis, B. abortus and B. suis were grouped into cluster 1, 2 and 3 respectively. The predominant genotype in the first cluster by MLST, remained unchanged during the three stages. However, the proportion of genotypes in the three stages had changed. More isolates were clustered in ST8 at the re-emergence stage. STs71-74, which were not found in the two former stages, appeared at the re-emergence stage.
conclusionsThe changing molecular epidemiology of brucellosis improve our understanding of apparent geographic expansion from the historically affected north of China to southern provinces in recent reemergence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.